Research - Cambridge, England, United Kingdom
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington's and other triplet repeat diseases.
Outlook
WordPress.org
Google Font API
Mobile Friendly